T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival

The oncogenetic landscape and clinical impact of <i>BCL11B</i> alterations in adult and pediatric T-cell acute lymphoblastic leukemia

(2023) Marie Emilie Dourthe et al.   HAEMATOLOGICA

Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial

(2022) Cunte Chen et al.   JCI Insight

How we treat NK/T-cell lymphomas

(2022) Eric Tse et al.   Journal of Hematology & Oncology

Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion

(2022) Hao Wang et al.   ONCOGENE

Single-cell deletion analyses show control of pro–T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b

(2022) Wen Zhou et al.   Science Immunology

The clinical features, treatment, and prognostic factors for peripheral T‐cell lymphomas: A single‐institution analysis of 240 Chinese patients

(2022) Haizhu Chen et al.   Asia-Pacific Journal of Clinical Oncology

High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma

(2022) Cunte Chen et al.   Biomarker Research

ASXL1/2 mutations and myeloid malignancies

(2022) Edward A. Medina et al.   Journal of Hematology & Oncology

Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T‐cell lymphoblastic lymphoma

(2022) Julia Salmerón‐Villalobos et al.   PEDIATRIC BLOOD & CANCER

Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia

(2022) Taotao Liang et al.   Frontiers in Immunology

Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia

(2022) Chen Tian et al.   Cell Death & Disease

Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)

(2021) Yuankai Shi et al.   Journal of Hematology & Oncology

Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia

(2021) Kehan Li et al.   Biomarker Research

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine

(2021) Sophie Voruz et al.   Experimental Hematology & Oncology

Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma

(2021) Cunte Chen et al.   Experimental Hematology & Oncology

Dismal outcome of relapsed or primary refractory adult T‐cell lymphoblastic lymphoma: A retrospective study from China

(2021) Haizhu Chen et al.   Asia-Pacific Journal of Clinical Oncology

TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma

(2021) Cunte Chen et al.   Cancer Cell International

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome

(2021) Xin Huang et al.   Biomarker Research

Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma

(2021) Peipei Wang et al.   Journal for ImmunoTherapy of Cancer

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

(2020) Si-Ye Chen et al.   LEUKEMIA

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

(2019) Fredrik Ellin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Aggressive T‐ cell Lymphomas: 2019 updates on diagnosis, risk stratification and management

(2019) Jasmine M. Zain   AMERICAN JOURNAL OF HEMATOLOGY

Switch hitter: Bcl11b in T cells and ILC2s

(2019) Christelle Harly et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients

(2014) Isabelle Bartram et al.   Journal of Hematology & Oncology

Role of the transcription factor Bcl11b in development and lymphomagenesis

(2012) Ryo KOMINAMI   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia

(2011) A. Gutierrez et al.   BLOOD

Down regulation ofBCL11Bexpression inhibits proliferation and induces apoptosis in malignant T cells byBCL11B-935-siRNA

(2011) Xin Huang et al.   Hematology

Gene expression profiles in BCL11B-siRNA treated malignant T cells

(2011) Xin Huang et al.   Journal of Hematology & Oncology

Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity

(2010) Pentao Liu et al.   IMMUNOLOGICAL REVIEWS

Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia

(2010) Xin Huang et al.   Journal of Hematology & Oncology

The TLX1 oncogene drives aneuploidy in T cell transformation

(2010) Kim De Keersmaecker et al.   NATURE MEDICINE